Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Fluticasone

Administration of inhaled corticosteroids (fluticasone, 0.5 mg) each 12 hours to 8 of the 16 COPD patients versus placebo.

DRUG

Inhaled Placebo

Trial Locations (1)

07198

Hospital Son Llatzer, Palma de Mallorca

All Listed Sponsors
collaborator

Sociedad Española de Neumología y Cirugía Torácica

OTHER

collaborator

Hospital Son Espases

OTHER

collaborator

Spanish Research Center for Respiratory Diseases

OTHER

collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

Fundació d'investigació Sanitària de les Illes Balears

OTHER_GOV

lead

Hospital Son Llatzer

OTHER

NCT02209974 - Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPD | Biotech Hunter | Biotech Hunter